Solasia Pharma K.K. (4597.T)
JPY 32.0
(-3.03%)
JPY 32.0
(-3.03%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 337 Million JPY | -124.62% |
| 2022 | 662 Million JPY | 77.01% |
| 2021 | 374 Million JPY | 52.65% |
| 2020 | 245 Million JPY | -80.32% |
| 2019 | 1.24 Billion JPY | 1085.71% |
| 2018 | 105 Million JPY | -74.41% |
| 2017 | 410.32 Million JPY | -18.01% |
| 2016 | 500.43 Million JPY | 118.09% |
| 2015 | 229.46 Million JPY | 1819.9% |
| 2014 | 11.95 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -93 Million JPY | 19.83% |
| 2024 Q2 | -32 Million JPY | 65.59% |
| 2023 Q4 | -116 Million JPY | -376.19% |
| 2023 Q1 | 129 Million JPY | -58.25% |
| 2023 Q2 | 161 Million JPY | 24.81% |
| 2023 Q3 | 42 Million JPY | -73.91% |
| 2023 FY | -163 Million JPY | -124.62% |
| 2022 Q3 | 225 Million JPY | 400.0% |
| 2022 Q1 | 83 Million JPY | -66.53% |
| 2022 FY | 662 Million JPY | 77.01% |
| 2022 Q4 | 309 Million JPY | 37.33% |
| 2022 Q2 | 45 Million JPY | -45.78% |
| 2021 Q3 | 5 Million JPY | -92.96% |
| 2021 FY | 374 Million JPY | 52.65% |
| 2021 Q1 | 50 Million JPY | -13.79% |
| 2021 Q2 | 71 Million JPY | 42.0% |
| 2021 Q4 | 248 Million JPY | 4860.0% |
| 2020 Q2 | 63 Million JPY | -44.25% |
| 2020 Q3 | 12 Million JPY | -80.95% |
| 2020 FY | 245 Million JPY | -80.32% |
| 2020 Q1 | 113 Million JPY | -88.71% |
| 2020 Q4 | 58 Million JPY | 383.33% |
| 2019 Q3 | 132 Million JPY | 164.0% |
| 2019 Q1 | 61 Million JPY | -7.58% |
| 2019 FY | 1.24 Billion JPY | 1085.71% |
| 2019 Q4 | 1 Billion JPY | 658.33% |
| 2019 Q2 | 50 Million JPY | -18.03% |
| 2018 Q4 | 66 Million JPY | 153.85% |
| 2018 Q3 | 26 Million JPY | 136.36% |
| 2018 Q2 | 11 Million JPY | 1000.0% |
| 2018 Q1 | 1 Million JPY | -25.6% |
| 2018 FY | 105 Million JPY | -74.41% |
| 2017 Q1 | 3.57 Million JPY | -98.81% |
| 2017 Q2 | 2.05 Million JPY | -42.64% |
| 2017 Q3 | 403.87 Million JPY | 19572.38% |
| 2017 FY | 410.32 Million JPY | -18.01% |
| 2017 Q4 | 1.34 Million JPY | -99.67% |
| 2016 Q4 | 300 Million JPY | 0.0% |
| 2016 FY | 500.43 Million JPY | 118.09% |
| 2016 Q3 | - JPY | -100.0% |
| 2016 Q2 | 1.31 Million JPY | -99.34% |
| 2016 Q1 | 200 Million JPY | 714.2% |
| 2015 Q3 | 1.9 Million JPY | 0.0% |
| 2015 Q4 | 24.56 Million JPY | 1191.48% |
| 2015 FY | 229.46 Million JPY | 1819.9% |
| 2014 FY | 11.95 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 48.75 Billion JPY | 99.309% |
| Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 99.985% |
| Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | 99.821% |
| Shionogi & Co., Ltd. | 369.08 Billion JPY | 99.909% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | 90.483% |
| Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | 99.653% |
| Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | 99.118% |
| Eisai Co., Ltd. | 586.41 Billion JPY | 99.943% |
| Morishita Jintan Co., Ltd. | 5.99 Billion JPY | 94.381% |
| Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | 99.573% |
| Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | 99.353% |
| Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | 97.507% |
| Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | 95.645% |
| Tsumura & Co. | 68.81 Billion JPY | 99.51% |
| Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | 99.098% |
| Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | 98.641% |
| Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | 99.586% |
| Fuji Pharma Co., Ltd. | 16.51 Billion JPY | 97.959% |
| Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | 99.328% |
| KYORIN Holdings, Inc. | 51.4 Billion JPY | 99.344% |
| Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | 68.767% |
| Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | 96.575% |
| SymBio Pharmaceuticals Limited | 4.41 Billion JPY | 92.36% |
| MedRx Co., Ltd | 26 Million JPY | -1196.154% |
| Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | 95.801% |
| Modalis Therapeutics Corporation | -731 Thousand JPY | 46201.231% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | 98.901% |
| Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | 99.38% |
| Cyfuse Biomedical K.K. | 37.74 Million JPY | -792.857% |
| Toho Holdings Co., Ltd. | 112.98 Billion JPY | 99.702% |
| Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | 94.924% |